LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER

The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center specializes in translational biomedical research, with deep expertise in clinical trial design, pharmacological evaluation, and reproductive health innovation. Their work centers on the preclinical and clinical development of novel therapeutics, including contraceptive agents, chemical entities, and behavioral health interventions. Technical capabilities encompass Phase I–III clinical trial execution, pharmacokinetic and pharmacodynamic modeling, formulation science (including SEDDS delivery systems), and data-driven evaluation of drug efficacy and safety profiles. The Institute distinguishes itself through its integrated clinical-research infrastructure, enabling end-to-end execution of complex biomedical studies with rigorous regulatory compliance and patient-centered protocols. The organization maintains a sustained and primary relationship with the Department of Health and Human Services, delivering research services across multiple operating divisions, including NIH and HRSA. Their engagements consistently support public health priorities in reproductive health, mental health technology development, and novel therapeutic evaluation, indicating a trusted role in advancing HHS’s biomedical innovation agenda through evidence-based, high-integrity science. Industry focus is firmly anchored in biotechnology research and development, particularly in non-nanobiotech applications involving pharmaceuticals and clinical interventions. While social science research appears occasionally, the core vertical is biomedical innovation—specifically in male contraception, chemical entity evaluation, and digital mental health tools. This positions the Institute as a niche provider of clinically grounded, FDA-relevant research services within the federal biotech ecosystem. As a non-profit research entity affiliated with Harbor-UCLA Medical Center, the Lundquist Institute operates as an academic-industrial hybrid with no formal government certifications. Located in Torrance, California, it leverages its academic medical center affiliation to access clinical populations, specialized laboratories, and regulatory expertise, strengthening its role as a mission-driven research partner for federal health initiatives.